Multiple Sclerosis

Multiple Sclerosis

An Overview of Clinical Features, Pathophysiology, Neuroimaging, and Treatment Options

Alireza Minagar
ISBN: 9781615045884 | PDF ISBN: 9781615045891
Copyright © 2014 | 117 Pages | Publication Date: 09/01/2014

BEFORE YOU ORDER: You may have Academic or Corporate access to this title. Click here to find out: 10.4199/C00116ED1V01Y201408ISP055

Ordering Options: Paperback $65.00   E-book $52.00   Paperback & E-book Combo $81.25

Why pay full price? Members receive 15% off all orders.
Learn More Here

Read Our Digital Content License Agreement (pop-up)

Purchasing Options:

Multiple sclerosis [MS] is one of the most common auto-immune-mediated diseases of the human central nervous system [CNS] which affects young adults and usually causes significant neurological disability. Currently, the causes of MS are still unclear, a cure for MS remains elusive and the effectiveness of treatment varies significantly among individuals. Clinical features and neurological deficits stemming from this progressive neurological disease are diverse since MS potentially affects human CNS at all levels from brain to the end of spinal cord. The triggering event for development of MS remains unknown. Immunopathogenesis of MS involves a number of steps which include activation of peripheral leukocytes against putative CNS antigen(s), interactions of the activated leukocytes with inflamed cerebral endothelial cells, transendothelial migration of activated lymphocytes and macrophages to the CNS milieu, and further propagation of the massive immune response within the CNS. Such massive immune activation leads to loss of myelin-oligodendrocyte complex. Several immune cell types and mediators of the immune-inflammatory response actively contribute to pathogenesis of MS. Genetic factors are also believed to play a central role in the development of most forms of MS. Another important but much unrecognized and under-researched feature of MS immunopathology is "neurodegeneration." Neuronal loss and axonal degeneration are the core components of irreversible and permanent CNS atrophy and disability in MS. What we call MS in reality is a heterogeneous group of diseases and at least four distinct immunopathological subtypes of MS with dissimilar responses to therapy with immunomodulatory agents exist. MS is a clinical diagnosis, however, its diagnostic process is much facilitated by utilization of laboratory and neuroimaging studies. Present therapies of MS are either immunomodulatory agents or immunosuppressive and mainly target the peripheral immune system with the intention to ameliorate the severity of acute relapses, decrease annual relapse rate, and improve MRI lesions. Currently, much research activity is being conducted to better understand the fundamental disease mechanisms of MS and find more effective and safer treatments for this incurable disease. This book presents an overview of MS as a disease with neuroinflammatory and neurodegenerative features and the authors discuss the most recent findings about MS and its treatment.

Table of Contents

Clinical Features of Multiple Sclerosis
Pathophysiology of Multiple Sclerosis
Neuroimaging of Multiple Sclerosis
Diagnosis of Multiple Sclerosis
Treatment of Multiple Sclerosis
Prognosis of Multiple Sclerosis
Concluding Remarks

About the Author(s)

Alireza Minagar, Department of Neurology, Louisiana State University Health Sciences Center
Dr. Alireza Minagar in a Professor in the Department of Neurology at Louisiana State University Health Sciences Center. He received his medical degree from the University of Teheran and completed his residencies and fellowship at New York University and the University of Miami. His research is focused on multiple sclerosis.

Browse by Subject
Case Studies in Engineering
ACM Books
IOP Concise Physics
SEM Books
0 items

Note: Registered customers go to: Your Account to subscribe.

E-Mail Address:

Your Name: